Coloplast A/S (0QBO) Share Forecast & Price Target

Compare

27 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0QBO Analyst Ratings

Hold

0 Buy

9 Hold

1 Sell

Based on 10 analysts giving stock ratings to

Coloplast

A/S

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0QBO Stock 12 Month Forecast

Average Price Target

kr692.80

▲(8.60%Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Coloplast A/S in the last 3 months. The average price target is kr692.80 with a high forecast of kr750.00 and a low forecast of kr640.00. The average price target represents a 8.60% change from the last price of kr637.92.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"626":"kr626","697":"kr697","768":"kr768","839":"kr839","910":"kr910"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":750,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">kr750.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":692.8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">kr692.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":640,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">kr640.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[626,697,768,839,910],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,627.4,636.8307692307692,646.2615384615384,655.6923076923076,665.123076923077,674.5538461538462,683.9846153846154,693.4153846153846,702.8461538461538,712.276923076923,721.7076923076922,731.1384615384616,740.5692307692308,{"y":750,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,627.4,632.4307692307692,637.4615384615385,642.4923076923077,647.5230769230769,652.5538461538462,657.5846153846154,662.6153846153845,667.6461538461538,672.676923076923,677.7076923076922,682.7384615384615,687.7692307692307,{"y":692.8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,627.4,628.3692307692307,629.3384615384615,630.3076923076923,631.276923076923,632.2461538461538,633.2153846153846,634.1846153846154,635.1538461538462,636.123076923077,637.0923076923077,638.0615384615385,639.0307692307692,{"y":640,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":796.82,"date":1717200000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":814.58,"date":1719792000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":873.97,"date":1722470400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":909.38,"date":1725148800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":855.81,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":849.11,"date":1730419200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":874.6,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":783.2,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":824.19,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":758.1,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":725.93,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":711.51,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":627.4,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Targetkr750.00

Average Price Targetkr692.80

Lowest Price Targetkr640.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Veronika DubajovaCiti

Citi

kr880→kr700

Hold

9.73%

Upside

Reiterated

06/05/25

Citi Sticks to Its Hold Rating for Coloplast A/S (0QBO)

Shubhangi GuptaHSBC

HSBC

kr860→kr670

Hold

5.03%

Upside

Downgraded

05/15/25

HSBC Downgrades Coloplast A/S (COLOB:DC) (CLPBY) to HoldHSBC analyst Shubhangi Gupta downgraded Coloplast A/S (COLOB:DC) (OTC: CLPBY) from Buy to Hold with a price target of DKK670.00 (from DKK860.00).

Graham DoyleUBS

UBS

kr858→kr690

Hold

8.16%

Upside

Reiterated

05/14/25

Coloplast A/S (COLOB:DC) (CLPBY) PT Lowered to DKK690 at UBSUBS analyst Graham Doyle lowered the price target on Coloplast A/S (COLOB:DC) (OTC: CLPBY) to DKK690.00 (from DKK858.00) while maintaining a Neutral rating.

Sam EnglandBerenberg Bank

Berenberg Bank

kr900→kr700

Hold

9.73%

Upside

Reiterated

05/14/25

Coloplast A/S (COLOB:DC) (CLPBY) PT Lowered to DKK700 at BerenbergBerenberg analyst Sam England lowered the price target on Coloplast A/S (COLOB:DC) (OTC: CLPBY) to DKK700.00 (from DKK900.00) while maintaining a Hold rating.

Jack Reynolds-ClarkRBC Capital

RBC Capital

kr940→kr700

Hold

9.73%

Upside

Downgraded

05/09/25

RBC Capital Downgrades Coloplast A/S (COLOB:DC) (CLPBY) to Sector PerformRBC Capital analyst Jack Reynolds-Clark downgraded Coloplast A/S (COLOB:DC) (OTC: CLPBY) from Outperform to Sector Perform with a price target of DKK700.00 (from DKK940.00).

Maja PatakiKepler Capital

Kepler Capital

kr870→kr715

Hold

12.08%

Upside

Reiterated

05/09/25

Kepler Capital Sticks to Their Hold Rating for Coloplast A/S (0QBO)

Anchal VermaJ.P. Morgan

J.P. Morgan

kr700→kr640

Hold

0.33%

Upside

Reiterated

05/07/25

Coloplast A/S (COLOB:DC) (CLPBY) PT Lowered to DKK640 at JPMorganJPMorgan analyst Anchal Verma lowered the price target on Coloplast A/S (COLOB:DC) (OTC: CLPBY) to DKK640.00 (from DKK700.00) while maintaining a Neutral rating.

Aisyah NoorMorgan Stanley

Morgan Stanley

kr694→kr655

Sell

2.68%

Upside

Reiterated

05/07/25

Coloplast A/S (COLOB:DC) (CLPBY) PT Lowered to DKK655 at Morgan StanleyMorgan Stanley analyst Aisyah Noor lowered the price target on Coloplast A/S (COLOB:DC) (OTC: CLPBY) to DKK655.00 (from DKK694.00) while maintaining a Underweight rating.

Hassan Al-WakeelBarclays

Barclays

kr1,010→kr750

Hold

17.57%

Upside

Downgraded

05/07/25

Barclays Downgrades Coloplast A/S (COLOB:DC) (CLPBY) to EqualweightBarclays analyst Hassan Al-Wakeel downgraded Coloplast A/S (COLOB:DC) (OTC: CLPBY) from Overweight to Equalweight with a price target of DKK750.00 (from DKK1,010.00).

Falko FriedrichsDeutsche Bank

Deutsche Bank

kr1,020→kr708

Hold

10.99%

Upside

Downgraded

05/05/25

Deutsche Bank Downgrades Coloplast A/S (COLOB:DC) (CLPBY) to HoldDeutsche Bank analyst Falko Friedrichs downgraded Coloplast A/S (COLOB:DC) (OTC: CLPBY) from Buy to Hold with a price target of DKK708.00 (from DKK1,020.00).

Lisa Bedell CliveBernstein

Bernstein

kr980

Buy

53.62%

Upside

Upgraded

01/29/25

Bernstein SocGen Group Upgrades Coloplast A/S (COLOB:DC) (CLPBY) to OutperformBernstein SocGen Group analyst Lisa Clive upgraded Coloplast A/S (COLOB:DC) (OTC: CLPBY) from Market Perform to Outperform with a price target of DKK980.00.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Veronika DubajovaCiti

Citi

kr880→kr700

Hold

9.73%

Upside

Reiterated

06/05/25

Citi Sticks to Its Hold Rating for Coloplast A/S (0QBO)

Shubhangi GuptaHSBC

HSBC

kr860→kr670

Hold

5.03%

Upside

Downgraded

05/15/25

Graham DoyleUBS

UBS

kr858→kr690

Hold

8.16%

Upside

Reiterated

05/14/25

Sam EnglandBerenberg Bank

Berenberg Bank

kr900→kr700

Hold

9.73%

Upside

Reiterated

05/14/25

Jack Reynolds-ClarkRBC Capital

RBC Capital

kr940→kr700

Hold

9.73%

Upside

Downgraded

05/09/25

Maja PatakiKepler Capital

Kepler Capital

kr870→kr715

Hold

12.08%

Upside

Reiterated

05/09/25

Kepler Capital Sticks to Their Hold Rating for Coloplast A/S (0QBO)

Anchal VermaJ.P. Morgan

J.P. Morgan

kr700→kr640

Hold

0.33%

Upside

Reiterated

05/07/25

Aisyah NoorMorgan Stanley

Morgan Stanley

kr694→kr655

Sell

2.68%

Upside

Reiterated

05/07/25

Hassan Al-WakeelBarclays

Barclays

kr1,010→kr750

Hold

17.57%

Upside

Downgraded

05/07/25

Falko FriedrichsDeutsche Bank

Deutsche Bank

kr1,020→kr708

Hold

10.99%

Upside

Downgraded

05/05/25

Lisa Bedell CliveBernstein

Bernstein

kr980

Buy

53.62%

Upside

Upgraded

01/29/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Coloplast A/S

1 Month

xxx

Success Rate

1/4 ratings generated profit

Average Return

0.00%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 25.00% of your transactions generating a profit, with an average return of 0.00% per trade.

3 Months

xxx

Success Rate

4/4 ratings generated profit

Average Return

+6.38%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +6.38% per trade.

1 Year

Aisyah NoorMorgan Stanley

Success Rate

4/4 ratings generated profit

Average Return

+12.90%

reiterated a sell rating last month

Copying Aisyah Noor's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +12.90% per trade.

2 Years

xxx

Success Rate

4/4 ratings generated profit

Average Return

+12.90%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +12.90% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0QBO Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0QBO has received 1 Buy Ratings, 11 Hold Ratings, and 2 Sell Ratings. 0QBO average Analyst price target in the past 3 months is 692.80.

Each month's total comprises the sum of three months' worth of ratings.

0QBO Financial Forecast

0QBO Earnings Forecast

Next quarter’s earnings estimate for 0QBO is kr5.32 with a range of kr3.89 to kr6.40. The previous quarter’s EPS was kr4.34. 0QBO beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.02% of the time in the same period. In the last calendar year 0QBO has Preformed in-line its overall industry.

0QBO Sales Forecast

Next quarter’s sales forecast for 0QBO is kr7.17B with a range of kr6.96B to kr7.33B. The previous quarter’s sales results were kr6.93B. 0QBO beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.48% of the time in the same period. In the last calendar year 0QBO has Outperformed its overall industry.

0QBO Stock Forecast FAQ

What is GB:0QBO’s average 12-month price target, according to analysts?

Based on analyst ratings, Coloplast A/S’s 12-month average price target is 692.80.

What is GB:0QBO’s upside potential, based on the analysts’ average price target?

Coloplast A/S has 8.60% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Coloplast A/S a Buy, Sell or Hold?

Coloplast A/S has a consensus rating of Hold, which is based on 0 buy ratings, 9 hold ratings and 1 sell ratings.

What is Coloplast A/S’s share price target?

The average share price target for Coloplast A/S is 692.80. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr750.00 ,and the lowest forecast is kr640.00. The average share price target represents 8.60% Increase from the current price of kr637.92.

What do analysts say about Coloplast A/S?

Coloplast A/S’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Coloplast A/S?

To buy shares of GB:0QBO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Coloplast A/S (0QBO) Share Forecast & Price Target

0QBO Analyst Ratings

0QBO Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Coloplast A/S

0QBO Analyst Recommendation Trends

0QBO Financial Forecast

0QBO Earnings Forecast

0QBO Sales Forecast

0QBO Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts